These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 37513627)

  • 1. Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?
    Guarano A; Capozzi A; Cristodoro M; Di Simone N; Lello S
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
    Cappelli V; Di Sabatino A; Musacchio MC; De Leo V
    Minerva Ginecol; 2013 Aug; 65(4):425-33. PubMed ID: 24051942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
    Genazzani AD; Prati A; Marchini F; Petrillo T; Napolitano A; Simoncini T
    Gynecol Endocrinol; 2019 Dec; 35(12):1088-1093. PubMed ID: 31304823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Alpha-lipoic acid improve effects on polycystic ovary syndrome?
    Laganà AS; Monti N; Fedeli V; Gullo G; Bizzarri M
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1241-1247. PubMed ID: 35253180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
    Artini PG; Obino MER; Micelli E; Malacarne E; Vacca C; Papini F; Cela V
    Gynecol Endocrinol; 2020 Sep; 36(9):755-759. PubMed ID: 32157927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
    Cirillo F; Catellani C; Lazzeroni P; Sartori C; Tridenti G; Vezzani C; Fulghesu AM; Madeddu E; Amarri S; Street ME
    Gynecol Endocrinol; 2020 Jul; 36(7):588-593. PubMed ID: 32054355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients.
    Stracquadanio M; Ciotta L; Palumbo MA
    Gynecol Endocrinol; 2018 Jun; 34(6):495-501. PubMed ID: 29265900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index.
    Genazzani AD; Battipaglia C; Petrillo T; Piacquadio N; Ambrosetti F; Arnesano M; Semprini E; Sponzilli A; Tomatis V; Simoncini T
    Gynecol Endocrinol; 2022 Aug; 38(8):681-688. PubMed ID: 35748584
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Fruzzetti F; Perini D; Russo M; Bucci F; Gadducci A
    Gynecol Endocrinol; 2017 Jan; 33(1):39-42. PubMed ID: 27808588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment.
    Cabrera-Cruz H; Oróstica L; Plaza-Parrochia F; Torres-Pinto I; Romero C; Vega M
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E237-E248. PubMed ID: 31874063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome.
    Fruzzetti F; Fidecicchi T; Palla G; Gambacciani M
    Gynecol Endocrinol; 2020 Feb; 36(2):152-155. PubMed ID: 31317814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment for polycystic ovary syndrome: focus on adolescence.
    Street ME; Cirillo F; Catellani C; Dauriz M; Lazzeroni P; Sartori C; Moghetti P
    Minerva Pediatr; 2020 Aug; 72(4):288-311. PubMed ID: 32418411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action.
    De Cicco S; Immediata V; Romualdi D; Policola C; Tropea A; Di Florio C; Tagliaferri V; Scarinci E; Della Casa S; Lanzone A; Apa R
    Gynecol Endocrinol; 2017 Sep; 33(9):698-701. PubMed ID: 28434274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.
    Fruzzetti F; Capozzi A; Canu A; Lello S
    Gynecol Endocrinol; 2019 Jun; 35(6):506-510. PubMed ID: 30612488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
    Lei W; Gao Y; Hu S; Liu D; Chen Q
    Medicine (Baltimore); 2020 Jul; 99(30):e20696. PubMed ID: 32791663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients.
    Genazzani AD; Battipaglia C; Rusce L; Prampolini G; Aio C; Ricciardiello F; Foschi M; Sponzilli A; Semprini E; Petrillo T
    Gynecol Endocrinol; 2024 Dec; 40(1):2341701. PubMed ID: 38622970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.